Blood Lymphocyte-to-Monocyte Ratio Identifies High-Risk Patients in Diffuse Large B-Cell Lymphoma Treated with R-CHOP

@inproceedings{Li2012BloodLR,
  title={Blood Lymphocyte-to-Monocyte Ratio Identifies High-Risk Patients in Diffuse Large B-Cell Lymphoma Treated with R-CHOP},
  author={Zhi-Ming Li and Jia-jia Huang and Y S Xia and Jian Sun and Ying Huang and Yu Wang and Ying-Jie Zhu and Yajun Li and Wei Zhao and Wen-Xiao Wei and Tongyu Lin and Hui-qiang Huang and Wenqi Jiang},
  booktitle={PloS one},
  year={2012}
}
BACKGROUND Recent research has shown a correlation between immune microenvironment and lymphoma biology. This study aims to investigate the prognostic significance of the immunologically relevant lymphocyte-to-monocyte ratio (LMR), in diffuse large B-cell lymphoma (DLBCL) in the rituximab era. METHODOLOGY/PRINCIPAL FINDINGS We analyzed retrospective data… CONTINUE READING